Picture of Kobayashi Pharmaceutical logo

4967 — Kobayashi Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeLarge CapHigh Flyer

Table: Kobayashi Pharmaceutical - 6-MTH group results

Jul 31 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2019        Jun 30, 2018     Dec 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               73.63               72.68           173.00    
                   (+1.3 pct)          (+8.0 pct)       (+3.3 pct)  
  Operating           11.42               11.60            27.30    
                   (-1.6 pct)          (+12.0 pct)      (+3.8 pct)  
  Recurring           11.64               11.53            27.90    
                   (+0.9 pct)          (+12.6 pct)      (+1.9 pct)  
  Net                  8.20                7.63            19.00    
                   (+7.5 pct)          (+8.4 pct)       (+5.4 pct)  
  EPS              104.26 yen           96.58 yen       240.29 yen  
  EPS Diluted                           96.50 yen                   
  Ann Div                               66.00 yen        68.00 yen  
  -Q2 div           33.00 yen           31.00 yen                   
  -Q4 div                               35.00 yen        35.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T

Recent news on Kobayashi Pharmaceutical

See all news